# Yum China Holdings Inc. (YUMC) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Biotechnology. Price $43.60, market value $14.8 billion.

## Valuation
- **P/E (trailing): 16.0×** (5-yr avg 26.1×, 3-yr avg 19.9×). Yum China Holdings Inc. trades at 16.0× trailing earnings, well below its own five-year average of 26.1×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 12.9×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 1.67**. A PEG of 1.67 is in the range usually read as fairly priced for its growth.
- **Price / sales: 1.2×**. Each dollar of revenue is priced at 1.2×.
- **Price / book: 2.9×**. The shares trade at 2.9× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 7.8×**. Enterprise value is 7.8× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 6.3%** (5-yr avg 3.7%). Free cash flow equals 6.3% of the market value, above its five-year average of 3.7%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 6.3%**. The inverse of the P/E: 6.3% of the price is earned each year.

## Profitability
- **Operating margin: 11.1%**. 11.1% of revenue is left after running the business.
- **Net margin: 7.9%**. 7.9% of each dollar of sales reaches the bottom line.
- **Return on equity: 17.3%**. 17.3% on shareholders' equity is solid.
- **Return on invested capital: 22.3%**. Return on all capital, debt included, is 22.3%: comfortably above what that capital costs.
- **Return on assets: 9.0%**. Each dollar of assets produces 9.0% of profit.

## Growth
- **Revenue growth (1 yr): 4.4%** (3-yr 7.2%/yr, 5-yr 7.4%/yr). Revenue grew 4.4% over the last year, against 7.4% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 7.7%** (3-yr 34.1%/yr, 5-yr 5.2%/yr). Earnings per share rose 7.7%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): 4.6%/yr**. Free cash flow has compounded at 4.6% a year over three years, lagging earnings: check whether profits are turning into cash.

## Financial health
- **Debt to equity: 0.01**. Debt is 0.01 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Yum China Holdings Inc. holds more cash than debt.
- **Altman Z-score: 4.09**. A Z-score of 4.09 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 2.66%** ($1.06 per share, trailing). Yum China Holdings Inc. yields 2.66%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 38%** (40% of free cash flow). 38% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 5**. 5 straight years of increases.
- **Dividend growth (5 yr): 32.0%/yr** (1-yr 50.0%). The dividend has compounded at 32.0% a year over five years, doubling roughly every 2 years at that pace.

## Analyst view
- **Analyst consensus: strong_buy** (21 analysts). 21 analysts cover Yum China Holdings Inc.; the consensus is strong_buy, with an average price target of $62.05 (+42% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -1.3%** (YTD -7.6%, 3-mo 1.7%). The shares are down 1.3% over twelve months including dividends.
- **From 52-week high: -25.3%** (8.6% above the low). Trading 25% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 35**. An RSI of 35 is neutral.
- **Beta (1 yr): 0.33** (volatility 25%). Beta of 0.33 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=YUMC · Page: https://foliofundamentals.com/stocks/yumc

Not investment advice.